Patents by Inventor Scott Lundahl

Scott Lundahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230321243
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Application
    Filed: May 5, 2023
    Publication date: October 12, 2023
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Patent number: 11690914
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Grant
    Filed: July 28, 2022
    Date of Patent: July 4, 2023
    Assignee: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Publication number: 20230145771
    Abstract: A method of performing photodynamic therapy is provided. The method includes applying, to the skin of a patient, a topical composition. The topical composition includes 5-aminolevulinic acid (ALA) hydrochloride, and a vehicle comprising at least one chelating agent to enhance accumulation of protoporphyrin IX (PpIX) in the skin. The method further includes incubating the topical composition, and following incubation, applying, to the skin, heat from a heat source for at least a first time period.
    Type: Application
    Filed: November 4, 2022
    Publication date: May 11, 2023
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Thomas BOYAJIAN, Mark CAROTA, Brian MAZEJKA, Pradeep SANGHVI, Scott LUNDAHL, Xiaopin JIN, Brenden B. HADJIKEZIAN, Jerzy ZADYKOWICZ, Haydar ABDALGHAFOR, Tasnuva HAQUE
  • Publication number: 20230131170
    Abstract: Methods and topical compositions for the treatment of a dermatological disorder are provided. The topical composition includes 5-aminolevulinic acid, at least one penetration enhancer and at least one chelating agent. Further, methods and topical compositions for use in photodynamic therapy are disclosed, in which the topical composition is applied to the affected area of a patient for a period in the range of about 15 minutes to about 10 hours.
    Type: Application
    Filed: October 19, 2022
    Publication date: April 27, 2023
    Inventors: Pradeep SANGHVI, Scott LUNDAHL, Xiaopin JIN, Brenden B HADJIKEZIAN, Jerzy ZADYKOWICZ, Haydar ABDALGHAFOR, Tasnuva HAQUE
  • Patent number: 11571478
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: February 7, 2023
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Publication number: 20220370610
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Application
    Filed: July 28, 2022
    Publication date: November 24, 2022
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott LUNDAHL, Michael GUTTADAURO
  • Patent number: 11433133
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: September 6, 2022
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Publication number: 20220008538
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Application
    Filed: September 28, 2021
    Publication date: January 13, 2022
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Patent number: 11135293
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: October 5, 2021
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Patent number: 11077192
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: August 3, 2021
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Publication number: 20210085788
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Application
    Filed: December 2, 2020
    Publication date: March 25, 2021
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott LUNDAHL, Michael GUTTADAURO
  • Publication number: 20190290763
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Application
    Filed: June 12, 2019
    Publication date: September 26, 2019
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott LUNDAHL, Michael GUTTADAURO
  • Patent number: 10357567
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: July 23, 2019
    Assignee: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Michael Guttadauro
  • Publication number: 20190216927
    Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.
    Type: Application
    Filed: January 12, 2018
    Publication date: July 18, 2019
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott LUNDAHL, Michael Guttadauro
  • Patent number: 10029116
    Abstract: This application is directed to a method of treating a patient with acne by applying a photodynamic agent to skin having acne lesions, waiting at least 12 hours, and then exposing the skin to which the photodynamic agent has been applied to light that causes an activation reaction.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: July 24, 2018
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventor: Scott Lundahl
  • Patent number: 9723991
    Abstract: An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity. A light sensor monitors output from the U-shaped tubes to provide a signal for adjusting the output from the tubes.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: August 8, 2017
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Scott Lundahl, Rebecca Kozodoy, Ronald Carroll, Elton Leppelmeier
  • Patent number: 9597150
    Abstract: The invention encompasses a method of inhibiting the growth of hair in skin including epilation of follicles in the skin, waiting until within 5 days of the commencement of metanagen, applying a photodynamic agent to the skin, and exposing the skin to photoactivating light.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: March 21, 2017
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventor: Scott Lundahl
  • Patent number: 9561276
    Abstract: This application is directed to a method of treating onychomycosis by applying a phototherapeutic agent to a nail structure, waiting for a period of at least three days, and exposing the nail to light that causes an activation reaction. The phototherapeutic agent may be amino levulinic acid, alkylated derivatives of ALA, and their pharmaceutically acceptable salts.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: February 7, 2017
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventor: Scott Lundahl
  • Publication number: 20160317831
    Abstract: This application is directed to a method of treating a patient with acne by applying a photodynamic agent to skin having acne lesions, waiting at least 12 hours, and then exposing the skin to which the photodynamic agent has been applied to light that causes an activation reaction.
    Type: Application
    Filed: July 11, 2016
    Publication date: November 3, 2016
    Inventor: SCOTT LUNDAHL
  • Publication number: 20160220674
    Abstract: This application is directed to a method of treating onychomycosis by applying a phototherapeutic agent to a nail structure, waiting for a period of at least three days, and exposing the nail to light that causes an activation reaction. The phototherapeutic agent may be amino levulinic acid, alkylated derivatives of ALA, and their pharmaceutically acceptable salts.
    Type: Application
    Filed: April 7, 2016
    Publication date: August 4, 2016
    Inventor: SCOTT LUNDAHL